Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1156, pseudogene (abbreviated as RNU6-1156P), is a human pseudogene corresponding to the U6 small nuclear RNA family[4]. U6 small nuclear RNA (U6 snRNA) is a highly conserved non-coding RNA that is a critical component of the spliceosome, the molecular machinery responsible for excising introns from pre-mRNA during splicing[1][3]. However, RNU6-1156P is annotated as a pseudogene, meaning it is a non-functional copy and does not produce a functional RNA molecule. Pseudogenes such as RNU6-1156P do not typically code for active products and are not considered therapeutic targets, receptors, enzymes, or direct contributors to cellular pathways[4]. In some cases, pseudogenes are known to have regulatory roles, such as acting as molecular decoys or regulating microRNA activity, but no such functions have been described for RNU6-1156P specifically[2]. There is no information linking RNU6-1156P to disease, druggability, or biomarker status. This entry is a correctly named human non-coding RNA pseudogene, is not considered a therapeutic target, and has no described biological or clinical relevance beyond genomic annotation[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1156, pseudogene (RNU6-1156P).